Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Rheumatology Women's Health Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial ● Currently Recruiting Non-phase study NCT06308770

Fatigue in Lupus Intervention Programmes (FLIP)

Fatigue in Lupus Intervention Programmes (FLIP) — Recruiting • Non-phase study • Infectious Disease • NCT06308770.

📅 07 May 2026 ⏱ 2 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
Phase
Non-phase study
NCT ID
NCT06308770
Start
2024-04-08
Completion
2026-09
ClinicaliQ Trial Snapshot
  • Fatigue in Lupus Intervention Programmes (FLIP) — Recruiting • Non-phase study • Infectious Disease • NCT06308770.
  • Virtual group fatigue management programme may reduce fatigue impact in lupus patients better than booklet alone.

Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.

Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

Systemic Lupus Erythematosus (SLE) is an autoimmune rheumatic disease. Patients report that fatigue has a significant impact on their quality of life but is often not discussed in healthcare settings. Fatigue is more prevalent in SLE than other Rheumatic diseases. Management across the NHS is very variable ranging from a booklet to one to one appointments or, less often, a group intervention. Previous studies in other Rheumatic diseases have shown that a group cognitive behavioural approach can be effective in helping patients manage their fatigue. The COVID-19 pandemic changed the…

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Clinical Brief
People Fixing The World
Infectious Disease · BBC Health · 01 Sep 2026
Sepsis Prevention, Detection and Treatment Early recognition is critical – Sepsis remains a major cause of mortality and morbidity; improving awareness and…
View brief →
Clinical Brief
Inside Health
Infectious Disease · BBC Health · 14 Jul 2026
HPV vaccination has significantly reduced cervical cancer incidence in vaccinated cohorts, prompting reconsideration of screening frequency and intensity in this population Cervical…
View brief →
Clinical Brief
Running costs of vaccine damage scheme more than double amount paid to victims
Infectious Disease · BBC Health · 11 Sep 2026
The Vaccine Damage Payment Scheme's administrative costs (£83m) now exceed compensation paid to victims, raising questions about scheme efficiency and resource allocation…
View brief →
Clinical Brief
New super flu vaccine rollout begins as NHS regroups from ‘busiest summer’
Infectious Disease · BBC Health · 31 Aug 2026
The NHS is rolling out an updated flu vaccine this season with modifications designed to improve protection against the Super-K strain, reflecting…
View brief →
Clinical Brief
Newborn ICU admissions drop 50% in first full year of RSV maternal vaccine programme
Infectious Disease · UKHSA · 12 Aug 2026
RSV maternal vaccination programme has achieved a 50% reduction in neonatal ICU admissions in its first full year of implementation, demonstrating significant…
View brief →
Clinical Brief
Pregnancy vaccine reduces baby hospital admissions for RSV by 80%
Infectious Disease · BBC Health · 17 Apr 2026
Maternal RSV vaccination reduces infant hospitalisation risk by 80%, offering significant protection against severe lower respiratory tract infection in the first months…
View brief →